tradingkey.logo
tradingkey.logo
Suchen

IDEXX Laboratories Inc

IDXX
Zur Watchlist hinzufügen
549.160USD
+7.850+1.45%
Handelsschluss 06/24, 16:00ETKurse um 15 Minuten verzögert
43.32BMarktkapitalisierung
40.13KGV TTM

mehr Informationen über IDEXX Laboratories Inc Unternehmen

IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, dairy and water testing industries. The Company also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.

IDEXX Laboratories Inc Informationen

BörsenkürzelIDXX
Name des UnternehmensIDEXX Laboratories Inc
IPO-datumJun 21, 1991
CEOEmerson (Andrew)
Anzahl der mitarbeiter11000
WertpapierartOrdinary Share
GeschäftsjahresendeJun 21
AddresseOne Idexx Drive
StadtWESTBROOK
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl04092-2041
Telefon12075560300
Websitehttps://www.idexx.com/
BörsenkürzelIDXX
IPO-datumJun 21, 1991
CEOEmerson (Andrew)

Führungskräfte von IDEXX Laboratories Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Lawrence D. (Larry) Kingsley
Mr. Lawrence D. (Larry) Kingsley
Independent Chairman of the Board
Independent Chairman of the Board
8.57K
+3.96%
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
8.43K
+3.05%
Mr. Michael J. Lane
Mr. Michael J. Lane
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
8.25K
-3.84%
Ms. Sharon E. Underberg
Ms. Sharon E. Underberg
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
6.89K
+2.86%
Mr. Andrew Emerson
Mr. Andrew Emerson
Executive Vice President, Chief Executive Officer, Treasurer
Executive Vice President, Chief Executive Officer, Treasurer
4.16K
-0.46%
Mr. Daniel M. (Dan) Junius
Mr. Daniel M. (Dan) Junius
Independent Director
Independent Director
3.35K
+7.66%
Mr. Michael Schreck
Mr. Michael Schreck
Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience
Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience
3.00K
+36.06%
Mr. Bruce L. Claflin
Mr. Bruce L. Claflin
Independent Director
Independent Director
1.72K
--
Ms. Irene Chang Britt
Ms. Irene Chang Britt
Independent Director
Independent Director
208.00
--
Ms. Karen Peacock
Ms. Karen Peacock
Independent Director
Independent Director
102.00
+99.02%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Lawrence D. (Larry) Kingsley
Mr. Lawrence D. (Larry) Kingsley
Independent Chairman of the Board
Independent Chairman of the Board
8.57K
+3.96%
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
8.43K
+3.05%
Mr. Michael J. Lane
Mr. Michael J. Lane
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
8.25K
-3.84%
Ms. Sharon E. Underberg
Ms. Sharon E. Underberg
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
6.89K
+2.86%
Mr. Andrew Emerson
Mr. Andrew Emerson
Executive Vice President, Chief Executive Officer, Treasurer
Executive Vice President, Chief Executive Officer, Treasurer
4.16K
-0.46%
Mr. Daniel M. (Dan) Junius
Mr. Daniel M. (Dan) Junius
Independent Director
Independent Director
3.35K
+7.66%

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von IDEXX Laboratories Inc?

Die fünf größten Anteilseigner von IDEXX Laboratories Inc sind: Mr. Lawrence D. (Larry) Kingsley

Wie viele Institutionen halten Anteile an IDEXX Laboratories Inc (IDXX)?

Mit Stand vom 2026Q1 halten 2458 Institutionen Anteile an IDEXX Laboratories Inc, mit einem Gesamtmarktwert von etwa 76.16M, was 96.54% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -2089033.00 gestiegen.

Was ist die größte Einnahmequelle von IDEXX Laboratories Inc?

Am 2026Q1 erzielte das Geschäft mit CAG Diagnostics recurring revenue für IDEXX Laboratories Inc den höchsten Umsatz in Höhe von 3.41B, was 79.17% des Gesamtumsatzes entspricht.
KeyAI